Poland· PL-100079300

Chibroxin

A norfloxacin product containing norfloxacinum, registered in Poland by Laboratoires Thea.

ATC S01AX12

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedChibroxinATCS01AX12REGISTER NO.PL-100079300PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Norfloxacinum
Manufacturer
Laboratoires Thea
Country
Poland (PL)
ATC code
S01AX12
ATC class
Norfloxacin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990753512

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Norfloxacin in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All norfloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Floxacin Stada, Norfloxacin Sandoz
  • Bulgaria · Нолицин
  • Cyprus · Gyrablock, Trizolin
  • Czechia · Gyrablock, Nolicin
  • Germany · Norfloxa, Norfloxacin 1 A Pharma
  • Estonia · Nolicin
  • Spain · Chibroxin, Norfloxacino Cinfa
  • France · Chibroxine, Norfloxacine Biogaran
  • Greece · Fluseminal, Norocin
  • Croatia · Noflox, Nolicin
  • Hungary · Nolicin, Nolicin-S
  • Italy · Naflox, Norfloxacina Abc
  • Lithuania · Nolicin
  • Latvia · Nolicin, Norflox
  • Malta · Norfloxacin Helcor
  • Netherlands · Norfloxacine Cf, Norfloxacine Sandoz
  • Portugal · Chibroxol, Norfloxacina Vitória
  • Romania · Nolicin, Norfloxacin Helcor
  • Slovenia · Nolicin
  • Slovakia · Gyrablock, Nolicin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3b6295d7-f212-435b-bd8e-592470485033
GET /v1/drugs/3b6295d7-f212-435b-bd8e-592470485033?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do oczu, roztwór",
  "source": "urpl",
  "strength": "3 mg/ml",
  "packaging": "05909990753512 ¦ Rp ¦ 54767\n1 butelka 5 ml",
  "substance": "Norfloxacinum 15 mg/5 ml",
  "common_name": "Norfloxacinum",
  "pl_product_id": "100079300",
  "pozwolenie_nr": "07535",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about norfloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.